NCT03546205View on ClinicalTrials.gov

A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal Function

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 6, 2018

Primary Completion Date

December 17, 2018

Study Completion Date

December 17, 2018

Conditions

Kidney Failure, Chronic

Interventions

DRUG

JNJ-64565111

All participants will receive a single SC dose of JNJ-64565111 solution on Day 1.

Trial Locations (2)

32809

Orlando Clinical Research Center, Orlando

37923

AMR New Orleans, Formerly New Orleans Center for Clinical Research - New Orleans, an AMR company, Knoxville

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY

NCT03546205 - A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal Function | Biotech Hunter | Biotech Hunter